Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.

Seminars in oncology

Volumn 24, Issue 4 Suppl 12, 1997, Pages

  Rosenthal, D I ^a   Okani, O ^a   Corak, J ^a   Kavanaugh, D ^a   Kamen, B ^a   Vuitch, F M ^a   Gazdar, A F ^a   Greiner, J ^a   Frenkel, E F ^a   Carbone, D P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL; RADIOSENSITIZING AGENT;

ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MEGAVOLTAGE RADIOTHERAPY; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, HIGH-ENERGY;

EID: 0031201598     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)